RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin*

We analyzed healthy human skin for the presence of endogenous antimicrobial proteins that might explain the unusually high resistance of human skin against infections. A novel 14.5-kDa antimicrobial ribonuclease, termed RNase 7, was isolated from skin-derived stratum corneum. RNase 7 exhibited potent ribonuclease activity and thus may contribute to the well known ribonuclease activity of human skin. RNase 7 revealed broad spectrum antimicrobial activity against many pathogenic microorganisms and remarkably potent activity (lethal dose of 90% < 30 nm) against a vancomycin-resistant Enterococcus faecium. Molecular cloning from skin-derived primary keratinocytes and purification of RNase 7 from supernatants of cultured primary keratinocytes indicate that keratinocytes represent the major cellular source in skin and that RNase 7 is secreted. RNase 7 mRNA expression was detected in various epithelial tissues including skin, respiratory tract, genitourinary tract, and at a low level, in the gut. In addition to a constitutive expression, RNase 7 mRNA was induced in cultured primary keratinocytes by interleukin-1β, interferon-γ, and bacterial challenge. This is the first report demonstrating RNases as a novel class of epithelial inducible antimicrobial proteins, which may play an important role in the innate immune defense system of human epithelia.

[1]  M. Sticherling,et al.  Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts. , 1996, Journal of immunology.

[2]  H. Rosenberg,et al.  The eosinophil ribonucleases , 1998, Cellular and Molecular Life Sciences CMLS.

[3]  Christina H. Park,et al.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. , 1998, The Journal of clinical investigation.

[4]  M. Zasloff,et al.  Expression of natural peptide antibiotics in human skin , 1997, The Lancet.

[5]  M. Kagnoff,et al.  Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. , 1999, Journal of immunology.

[6]  S. Krisanaprakornkit,et al.  Expression of the Peptide Antibiotic Human β-Defensin 1 in Cultured Gingival Epithelial Cells and Gingival Tissue , 1998, Infection and Immunity.

[7]  H. Rosenberg Recombinant Human Eosinophil Cationic Protein , 1995, The Journal of Biological Chemistry.

[8]  L. Schwichtenberg,et al.  Mucoid Pseudomonas aeruginosa, TNF- α , and IL-1 β , but Not IL-6, Induce Human β -Defensin-2 in Respiratory Epithelia , 2000 .

[9]  Jianzhi Zhang,et al.  RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. , 2002, Nucleic acids research.

[10]  J. Schröder,et al.  Neutrophil-activating proteins in psoriasis. , 1992, The Journal of investigative dermatology.

[11]  M. Frohman,et al.  Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[13]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[14]  K. Dyer,et al.  Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. , 1998, Nucleic acids research.

[15]  T. Ganz,et al.  Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. , 1989, Journal of immunology.

[16]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[17]  J. Schröder,et al.  A peptide antibiotic from human skin , 1997, Nature.

[18]  J. Schröder,et al.  Human beta-defensin-2. , 1999, The international journal of biochemistry & cell biology.

[19]  R. Bals,et al.  Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  H. G. Boman,et al.  Gene‐Encoded Peptide Antibiotics and the Concept of Innate Immunity: An Update Review , 1998, Scandinavian journal of immunology.

[21]  J. Schröder Epithelial peptide antibiotics. , 1999, Biochemical pharmacology.

[22]  Wayne L. Smith,et al.  Purification, primary structures, and antibacterial activities of β-defensins, a new family of antimicrobial peptides from bovine neutrophils. , 1996, The Journal of Biological Chemistry.

[23]  J. L. Bethune,et al.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. , 1985, Biochemistry.

[24]  M. Raida,et al.  hBD‐1: a novel β‐defensin from human plasma , 1995 .

[25]  R. Jackson,et al.  Ultrasensitive assays for endogenous antimicrobial polypeptides. , 1991, Journal of immunological methods.

[26]  Christina H. Park,et al.  Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. , 2002, The Journal of investigative dermatology.

[27]  E. Christophers,et al.  Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes. , 1998, Biochemical and biophysical research communications.

[28]  Nikolaus Blin,et al.  Dermcidin: a novel human antibiotic peptide secreted by sweat glands , 2001, Nature Immunology.

[29]  H. Wigzell,et al.  The Expression of the Gene Coding for the Antibacterial Peptide LL-37 Is Induced in Human Keratinocytes during Inflammatory Disorders* , 1997, The Journal of Biological Chemistry.